GlassScriptPhysician profile
Mario A Gomez
NPI 1033386131
$4,092.05
in general payments reported to CMS, 2019-2025
19 companies · $241 in 2025
The $241 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $83.16 · 2020: $26.11 · 2021: $86.18 · 2022: $154 · 2023: $3,263 · 2024: $239 · 2025: $241.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $3,000 · Food and Beverage: $743.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $3,000.00 |
| Food and Beverage | $742.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,000.00 | 2023 | Davinci Xi |
| Abbvie INC. | $268.49 | 2020-2023 | |
| Hologic Sales and Service, LLC | $148.70 | 2022-2025 | Aptima, Thinprep 2000 Processor |
| Astellas Pharma US INC | $120.37 | 2022-2023 | Veozah |
| Exeltis, USA INC. | $91.55 | 2023-2025 | Slynd |
| Innovation Technologies INC | $68.36 | 2024 | Irrisept |
| Mayne Pharma Commercial LLC | $59.86 | 2025 | |
| Biogen, INC. | $56.32 | 2024-2025 | Zurzuvae |
| Duchesnay USA Incorporated | $46.17 | 2019 | |
| Evofem Biosciences, INC. | $41.54 | 2024-2025 | Solosec, Phexx, Phexxi |
| Paratek Pharmaceuticals, INC. | $40.70 | 2024-2025 | Nuzyra |
| Mission Pharmacal Company | $36.99 | 2019 | |
| Axonics, INC. | $23.07 | 2023 | Axonics |
| Shield Therapeutics INC | $20.06 | 2023 | Accrufer |
| Medicem INC. | $18.78 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanara Medtech INC. | $18.61 | 2025 | Celleraterx |
| Coopersurgical, INC. | $17.80 | 2021 | |
| Avion Pharmaceuticals | $14.68 | 2020 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mario Gomez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.